삼성서울병원

Ko En

Radiation Oncology Park, Hee Chul M.D

Expertise
Liver cancer, biliary and pancreatic cancer, rectal cancer, radiation therapy, proton therapy
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

2002~2004 Ph.D. in Medicine Yonsei University, Korea
1999~2001 Master of Science Yonsei University, Korea
1986~1992 Medical Doctor College of Medicine, Yonsei University, Korea

Post-Graduate Training

Fellowship   2001~2001 Department of Radiation Oncology, Yonsei University College of Medicine, Korea
Residency   1996~2000 Department of Radiation Oncology, Severance Hospital, Korea
Internship   1992~1993 Severance Hospital, Korea

Professional Appointments

2021~Present Chair Department of Radiation Oncology, Samsung Medical Center
2016~Present Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2010~2015 Associate Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2006~2007 Visiting Scientist Department of Radiation Oncology, MD Anderson Cancer Center, USA
2006~2006 Honorable Visiting Instructor Department of Radiology, Hokkaido University Hospital, Japan
2001~2005 Assistant Professor Department of Radiation Oncology, Hallym University College of Medicine

Professional Memberships

1996~Present Member The Korean Society for Radiation Oncology
2009~Present Member The Korean Liver Cancer Association
2008~Present Member Korean Society of Medical Oncology

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-90065-1 Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma Lee1, JH; Yoo, GS; Yoon, YC; Park, HC; Kim, HS
    View PubMed
  • INT J MOL SCI 2021 10.3390/ijms22052637 Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments Shin1, SW; Yang, K; Lee, M; Moon, J; Son, A; Kim, Y; Choi, S; Kim, D; Choi, C; Lee, N; Park, HC
    View PubMed
  • CELLS 2021 10.3390/cells10030554 Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells Choi1, C; Lee, GH; Son, A; Yoo, GS; Yu, JI; Park, HC
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-82177-5 Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma Yu1, JI; Park, HC; Yoo, GS; Choi, C; Choi, MS; Nam, H; Baek, SY; Park, M
    View PubMed